No Data
No Data
There is no limit on price fluctuation, new stocks are being speculated! The pioneer of ultrasound submits an application for registration on the gem.
Cumulative dividends exceed 0.3 billion in 4 years.
ACOTEC-B: 2024 INTERIM REPORT
Acotec Scientific Gets China Registration Nod for Aortic Dilation Catheter
Sinopharm Medical-B (06669.HK): The registration application of the heart valve balloon dilatation catheter RUNFLOW has been approved by the National Medical Products Administration.
On September 23, Gleghorn reported that Sanofi medical (06669.HK) announced that on September 19, 2024, the group received registration approval from the China National Medical Products Administration for the RunFlow coronary valve dilatation catheter. RunFlow is used in aortic valve replacement surgery for the dilation of the autologous aortic valve. The product adopts an eight-balloon cavity structure design, which allows smooth blood flow even when the balloon is fully inflated, effectively improving the safety of the surgery and simplifying the operation. The company will conduct marketing activities in China in a timely manner.
Express News | Acotec Scientific - Approval for Cardiac Valve Balloon Dilation Catheter Runflow by PRC Nmpa
Sinopharm Medical-B (06669) released its interim performance, with a net income of 39.957 million yuan, a year-on-year increase of 78.6%.
Xian Ruida Medical-B(06669) released its six-month performance for the period ending June 30, 2024, with earnings of 2.92...
No Data
No Data